Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate in Young Children With Developmental Disorders
NCT00517504Phase 4Completed
- Sponsor
- University of Arizona
- Start
- May 2001
- Primary completion
- Mar 2008
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Arizona. Primary endpoints: Conners Rating Scale-Revised Hyperactive-Impulsive Subscale and Clinician's Global Improvement. Started May 2001; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00517504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517504.